The prospective contribution and the global and integrated approach to pharmaceutical industry s new challenges.

Similar documents
Current Status and Challenges of Bilateral/Multilateral Meetings

ICH Q12 (Pharmaceutical Product Lifecycle Management): PMDA Perspective

(Fig.) JPMA Industry Vision 2025

Twenty-Thirty Health care Scenarios - exploring potential changes in health care in England over the next 20 years

Issues in Emerging Health Technologies Bulletin Process

Finn Børlum Kristensen, MD, PhD Director, EUnetHTA Secretariat Danish Health and Medicines Authority (EUnetHTA Coordinator) Copenhagen, Denmark

December Eucomed HTA Position Paper UK support from ABHI

Telehealth and Digital Technology. Libbe Englander, PhD

e-care Living Lab - 5 avenue du Grand Sablon La Tronche - FRANCE Tel: +33 (0)

'INNOVATIVE SOLUTIONS FOR RESEARCH IN HEALTHCARE' Developing a novel approach to deliver better precision medicine in Europe The EMA standpoint

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

Digital Health Startups A FirstWord ExpertViews Dossier Report

FDA Centers of Excellence in Regulatory and Information Sciences

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data

CADTH HEALTH TECHNOLOGY MANAGEMENT PROGRAM Horizon Scanning Products and Services Processes

SHTG primary submission process

SENIOR CITIZENS ARE RIDING THE DIGITAL HEALTH WAVE

Cultural Evolution Is the future in our own hands?

The Role of Patients in Transitions of Care

HERE AND NOW. Creating a New Vision for Your Life With Chronic Illness

How machines learn in healthcare

Before I talk through the strategy itself, I want to tell you more about why

INTRODUCTION OUR VISION: We are driven to be a preeminent college of pharmacy in the world. Our world begins in Iowa. OUR MISSION:

Acquisition of MST Medical Surgery Technologies Ltd:

Capability to Transform Care Delivery

USTGlobal. Internet of Medical Things (IoMT) Connecting Healthcare for a Better Tomorrow

Development and Integration of Artificial Intelligence Technologies for Innovation Acceleration

The Future of Patient Data The Global View Key Insights Berlin 18 April The world s leading open foresight program

Enhancing Government through the Transforming Application of Foresight

The Changing Face of Product and Process Development in the QbD Era. James Kraunsoe AstraZeneca Product Development UK/US

Security and Risk Assessment in GDPR: from policy to implementation

EXPLORING THE POSSIBILITIES

Torsti Loikkanen, Principal Scientist, Research Coordinator VTT Innovation Studies

Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities

Comprehensive Research Services

Foresight in Public Service

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

Industry at a Crossroads: The Rise of Digital in the Outcome-Driven R&D Organization

EMA experience with the review of digital technology proposals in medicine development programmes

Executive Summary Industry s Responsibility in Promoting Responsible Development and Use:

Transforming How We Manage Health Technologies in Support of Better Health, Better Patient Experience, and Better Value

Refining foresight approaches to crisis, inertia and transition

The robots are coming, but the humans aren't leaving

A SYSTEMIC APPROACH TO KNOWLEDGE SOCIETY FORESIGHT. THE ROMANIAN CASE

Driving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif

FOREST PRODUCTS: THE SHIFT TO DIGITAL ACCELERATES

Impacts and Risks Caused by AI Networking, and Future Challenges

CEOCFO Magazine. Pat Patterson, CPT President and Founder. Agilis Consulting Group, LLC

Medical Device Usability Engineering. Product and Service Design Innovation Consultancy

Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry

LEGAL TRANSFORMATION STUDY

Making lives better every day. This is UCB

Health & Social Care Industrial Innovation

E5 Implementation Working Group Questions & Answers (R1) Current version dated June 2, 2006

HOW AI BOOSTS INDUSTRY SPOTLIGHTS INDUSTRY PROFITS AND INNOVATION

IHT at the HTAi A parallel workshop June 2005 Rome. Introduction Andrew Webster Programme Director

Inter-Association Task Force

LANGUAGE SPEAK YOUR DOCTOR S. Take Control of Your Arthritis: and get the most from your visit

Report for the Global South ehealth Observatory THE VIRTUOUS LINK BETWEEN PATIENTS, PHARMACIES AND PHARMACEUTICAL GROUPS.

MovingLife Project and mhealth in Denmark

The Cuban Scientific Advisor's Office: Providing science advice to the government

A manifesto for global sustainable health. Sustainable Health Symposium Cambridge, UK 25th July 2017

A Case Study on the Use of Unstructured Data in Healthcare Analytics. Analysis of Images for Diabetic Retinopathy

Strategic Foresight Initiative 2011 Summary Briefing

Trends Report R I M S

Feature. Accelerate Business Development Contributing to Further Enhance Ophthalmic Treatment in Asia. 2020, our goal is to become #1 in

Ibero-American Engineer Profile

GUIDE TO SPEAKING POINTS:

25 th Workshop of the EURORDIS Round Table of Companies (ERTC)

Reduce cost sharing and fees Include other services. Services: which services are covered? Population: who is covered?

Jagadguru Sri Shivarathreeshwara University (Deemed University) Accredited A Grade by NAAC ONE DAY SEMINAR

Future Personas Experience the Customer of the Future

SUCCESSFULLY IMPLEMENTING TRANSFORMATIONAL TECHNOLOGY IN HOSPITALS AND HEALTH SYSTEMS

Five-year strategy. Harnessing the power of evidence and ideas. Evidence. Ideas. Change. Evidence. Ideas. Change.

Virtual Mentor American Medical Association Journal of Ethics December 2006, Volume 8, Number 12:

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Powered by: Norway for Life Science. Photo cover: Christopher Olssøn Design: Fete typer

The Policy Content and Process in an SDG Context: Objectives, Instruments, Capabilities and Stages

THE PILLARS THAT SUPPORT US

NSW Digital+ Public Consultation

The Impact of Foresight on policy-making - Drawing the landscape

Design and Transform Value in Health: A Service Ecosystem Framework INTRODUCTION

Roche in Mannheim. The high-tech campus

Medical Devices cyber risks and threats

Venture Capital Search Highlights

Implementing Quality Systems

PHARMACEUTICALS: WHEN AI ADOPTION HAS GATHERED MOST MOMENTUM.

Supporting Consumers Facilitating Behaviour that Reduces Risky Behaviours. Professor Lynn J. Frewer. Food and Society Group

A/AC.105/C.1/2016/CRP.21

Asia Pacific s leading event serving the entire value chain of the medical device market. CMEF & ICMD Spring 2016 Post- Show Report

Minimally Invasive Therapies Group

ABCPhD CALL4SCHOLARSHIP 33 Research topic: Design for All in Healthcare Facilities

DIGITAL OUTLOOK LIFE SCIENCES INDUSTRY

DESTINATION FEELGOOD. Minor 30 EC Offered in fall and spring semester. Interested? Get in touch with Timo Derriks for more information

Achieving. A Roadmap. Profession. for the. Prepared by the ASCE Task Committee to Achieve the Vision for Civil Engineering in 2025

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

Implementation of Systems Medicine across Europe

Towards a Consumer-Driven Energy System

COM C. Rozwell

JOB DESCRIPTION. Department: Technical Length of contract: 3 years renewable. Reporting to: Chief of Party Direct reports: Numbers to be confirmed

Transcription:

The prospective contribution and the global and integrated approach to pharmaceutical industry s new challenges. Dr. Catherine FRADE Strategic Prospective Director AXELPHARM 22nd Annual EuroMeeting March 8-10, 2010 Monaco

Dr. Catherine FRADE, Founder of AXELPHARM Pharm. D., Psychologist of work, Business Coach Axelpharm develops in a multicultural and multidisciplinary way: 1. Health Prospective to accelerate the development processes in the Health and Pharmaceutical industries 2. Management and innovation 3. Professional development 2

Prospective contribution and the global (comprehensive) and integrated approach to pharmaceutical industry s new challenges prospective = strategic foresight 1. Definition of prospective 2. How a global and integrated approach is both useful and necessary. 3. Impact of a new global vision on the existing and new jobs 3

The needs The world is changing The health industries must face these changes in operational and timely ways Do we want it changes with us without us or against us? Proactive or preactive attitude Strategic foresight and scenarios planning 4

1. WHAT DOES A PROSPECTIVE APPROACH MEANS? Prospective enables to : build strategies that start in the present, take decisions in the present, by making sense of the future from a thread that begins in the future Prospective helps : putting things into perspective making sense of long term evolutions 5

Prospective, strategic in nature, is a knowledge lever to act A way : of asking questions before bringing solutions, of promoting intellectual questioning, to foster an existential doubt to imagine all possible scenarios in order to act today for tomorrow. 6

a. How the prospective allows to take risks Short Term Vision : immediate and irreversible decisions : caution Long Term Vision distant and broad horizon : boldness Even if predicted actions amended 7

b. Thinking about the human being The path to a true construction of the future. - what can happen - what people wish to happen Better to foresee what would happen if people don t do any changes Prospective frees people from fate And leads them to action 8

The objective of the prospective is to study the far future Observe the present from the future Permanent confrontation between : ends, ways and reality 1. Foresee far further : In complement to short term vision 10 or 20 years 9

The study of a far future 2. See the global picture + comprehensive view Discussion between experts to obtain a common complementary view In interdisciplinary fields, various experiences and cultural backgrounds 3. Do in-depth analysis: To identify essential factors To refuse methods based on habits and routine 10

In concrete business terms? To bring out the deep meaning of events To develop plans and programs To give recommendations immediately effective To set up possible objectives To challenge companies rules & objectives constantly 11

Application To detect: Obvious trends Weak signals Past mistakes to avoid Scenarios Possible or Desirable future situations To avoid unwelcome future situations 12

Principles of the strategic foresight 6 fundamental questions 1.Who am I? 2.Where do we come from? 3.What can happen? 4.What can I do? 5.What will I do? 6.How can I do it? Ask the right questions to choose the right processes 13

Principles of the strategic foresight 6 main principles 1. To be far-sighted : 10-20 years in the health field 2.To see the big picture 3.To do in depth analysis 4. To take risks : always better than not taking risks 5. To think about the human being 6.To work together : impossible to do strategic foresight alone! 14

Attitude of the strategic foresight 4 attitudes facing the future 1.Passivity : to undergo the changes 2. Reactivity : to act in urgency 3. Preactivity : to be prepared to predictable events 4. Proactivity : to act to produce desirable changes One common objective : the future (responsibility) Preactivity and Proactivity to reduce Reactivity Time concept: Past = experience // Present controllable 15

Attitude of the strategic foresight 7 fundamental virtues 1.Peace and quiet 2.Imagination and intuition 3.Team spirit 4. Enthusiasm : for innovation 5.Courage 6.Meaning of human understanding, without judging 7. Humility 16

The aim of strategic foresight : to break organisational silence Increase the light to decrease the darkness Take into account the minorities instead of excluding them Don t be blinded by dominant ideas Innovate and dare to say other than the corporate language 17

5 methods of the prospective (workshops) 1. From received ideas to action Hunting for received ideas (positive or negative) 2. From change factors and inertia to action Structural analysis Importance Critical changes Effective strength Non guilty strengths Useful strengths Control 18

5 methods of the prospective (workshops) 3. From change factors to exploratory scenarios Morphological analysis Multicriteria analysis to identify and evaluate strategic options Key Fields R & D Regulatory Financial Possible actions Probabilization by experts to reduce uncertainty Marketing Coherent strategies Strategy X (1,2,2,1) Strategy Y (2,2,3,2) Strategy Z (3,4,3,3) 19

5 methods of the prospective (workshops) 4. From change factors to the game of the actors Analysis of the acting strategies Influence Dominant actors Autonomous actors Relay actors Dominated actors Dependance 20

5 methods of the prospective (workshops) 5. Building the skill tree of the past, present and future Quality of life SKILL ENHANCEMENT Production, Industry, Service, Agriculture Welcome collective will Inter territoriality Network Production tools Regulation TRUNK SKILLS AND KNOWHOW Geography History Research Training Territories knowledge and skills generated Education Knowledge ROOTS ROOTS Know-How Values 21

Prospective contribution and the global (comprehensive) and integrated approach to pharmaceutical industry s new challenges prospective = strategic foresight 1. Definition of prospective 2. How a global and integrated approach is both useful and necessary. 3. Impact of a new global vision on the existing and new jobs 22

2. IMPACT ON THE GLOBAL HEALTH CARE SYSTEM Demographic and epidemiological evolutions Research and development evolutions Increasing regulations Global healthcare packages Patient s needs as a whole 23

By 2020, the pharmaceutical, payer and provider value chains will be much more closely intertwined* * Source : PricewaterhouseCoopers 24

Healthcare delivery closer to the patient* Secondary care (specialty medicine) In 2007 In 2020 Hospital ER, diagnosis, intensive care, light surgical interventions, important surgical acts, other consultations Primary care (general medicine) Secondary care (specialty medicine) Hospital ER, diagnosis, Intensive care, Major surgical acts First diagnosis, Prescription, Routine check-up Patient Self-medication OTC drugs, Routine medical advice Primary care (multidisciplinary health agencies) Diagnosis and complex treatments, Minor surgical interventions, Diagnosis and simple prescriptions by Pharmacists/ Nurses ; Health check-up, Prevention. Self-medication Patient Autodiagnosis on Internet, OTC drugs for chronic and non chronic diseases, Wellness and comfort services * Source : PricewaterhouseCoopers 25

Prospective contribution and the global (comprehensive) and integrated approach to pharmaceutical industry s new challenges prospective = strategic foresight 1. Definition of prospective 2. How a global and integrated approach is both useful and necessary. 3. Impact of a new global vision on the existing and new jobs 26

3. IMPACT ON PHARMACEUTICAL JOBS BY 2020 Existing jobs : in regulation, marketing and sales, research, epidemiology New emergent jobs : we must be ready to have the right training, on-going education and life time training. 27

Who is concerned? The general management Strategy and planning Business development Strategic foresight actors (new job?) CONCLUSION 28

Questions and Answers 29

Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. ( DIA ), its directors, officers, employees, volunteers, members, chapters, councils, Special Interest Area Communities or affiliates, or any organization with which the presenter is employed or affiliated. These PowerPoint slides are the intellectual property of the individual presenter and are protected under the copyright laws of the United States of America and other countries. Used by permission. All rights reserved. Drug Information Association, DIA and DIA logo are registered trademarks or trademarks of Drug Information Association Inc. All other trademarks are the property of their respective owners. 30